Agents Used in Antiretroviral Therapy

  • Authors: Philip Grant, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/9/19 (What's New)

Summary

  • Fusion inhibitors block fusion of HIV with host cell membrane
  • Currently only 1 fusion inhibitor approved by FDA: enfuvirtide (Table 16)
    • Enfuvirtide
    • Enfuvirtide, in combination with other antiretroviral agents, is indicated for treatment of HIV infection in treatment-experienced patients with evidence of HIV replication despite ongoing antiretroviral therapy[FDA Enfuvirtide]

Action required

Keywords: Dermatologic Complications, Initial Antiretroviral Therapy, Management of Treatment-Experienced Patients, Special Populations, Treatment Complications

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.